PD67 Subsidy Of Monoclonal Antibodies In Brazil: What Criteria Influence Decisions by the National Committee for Health Technology Incorporation (CONITEC)?

André Motta-Santos, Daniel Reis, Júlia Tupinambás, Lélia Carvalho, Karina Zocrato, Marcela Freitas, Marcus Borin, Maria Horta, Clarice Petramale, Silvana Kelles, Sergio Bersan · 2025

Read PD67 Subsidy Of Monoclonal Antibodies In Brazil: What Criteria Influence Decisions by the National Committee for Health Technology Incorporation (CONITEC)? by André Motta-Santos, Daniel Reis, Júlia Tupinambás, Lélia Carvalho, Karina Zocrato, Marcela Freitas, Marcus Borin, Maria Horta, Clarice Petramale, Silvana Kelles, Sergio Bersan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768734.txt.

Description

André Motta-Santos and co-authors wrote a 2025 study on how Brazil's national review body decides to fund monoclonal antibodies. These lab-made antibodies are powerful but costly drugs. Their high price makes the grounds for each funding choice more important to state clearly.

The team read all reports by the body on such drugs from 2019 to 2024. After cleaning, 53 reports covered 37 drugs judged for 45 uses. The team tested which factors tracked with a yes or no verdict, using standard statistical tests. They set a loose bar for significance, given the small sample. The study aims to make the choice process more open, so firms, doctors, and patients can see what sways the panel.

Catalog record

CREATORAndré Motta-Santos, Daniel Reis, Júlia Tupinambás, Lélia Carvalho, Karina Zocrato, Marcela Freitas, Marcus Borin, Maria Horta, Clarice Petramale, Silvana Kelles, Sergio Bersan
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12768734

Browse the full library · About the Tower of Babel